Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.
Hirai Y, Sakurai J, Yoshida S, Kikuchi T, Mitsuhashi T, Miyake T, Fujimura T, Abe R, Fujikawa H, Boki H, Suga H, Shibata S, Miyagaki T, Shimauchi T, Kiyohara E, Kawakami Y, Morizane S.
Hirai Y, et al. Among authors: kawakami y.
J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17324. Online ahead of print.
J Dermatol. 2024.
PMID: 38874430